Oil prices tiptoed within a tight range on Friday, dancing to the rhythm of strong labor data that ignited fears of climbing U.S. interest rates. But hey, they’re not letting that dampen their spirits! These slick prices are gearing up for a second week of gains, flaunting signs of tighter supplies and a boost in demand.
Hold your horses, because Thursday’s data dropped a bombshell! U.S. inventories decided to shrink even more than anticipated during the week leading up to June 30. And guess what? Gasoline inventories took a plunge that left everyone gasping, hinting at a glorious surge in fuel demand during this summer season of wanderlust.
This eye-opening revelation helped the crude market maintain its cool on Thursday.
While the broader financial markets trembled under the influence of strong private payrolls data, indicating a robust U.S. labor market, our oil buddies managed to steer clear of the chaos. The worrywarts are fretting that the Federal Reserve will keep its beady hawk eyes on interest rates, but our resilient oil prices are here to stay!
Dow futures steady, Levi’s falls 6.2% after earnings
U.S. stock futures were trading lower on Thursday evening, following a negative session among benchmark indices as stronger-than-expected ADP employment data renewed concerns of further rate hikes from Federal Reserve policymakers.
In extended deals, Levi Strauss & Co Class A (NYSE:LEVI) lost 6.2% after reporting Q2 EPS of $0.04 versus $0.03 expected, while revenues were reported at $1.34 billion versus $1.34 billion expected. The company also forecasted FY2023 EPS in the range of $1.10-$1.20 versus $1.29 expected.
During Thursday’s session, the Dow Jones Industrial Average fell 366.4 points or 1.1% to 33,922.3, the S&P 500 lost 35.2 points or 0.8% to 4,411.6 and the NASDAQ Composite dipped 112.6 points or 0.8% to 13,679.
On the bond markets, United States 10-Year rates lifted to fresh multi-month highs of 4.031%.
Some of the biggest movers:
Finally, a breakthrough that leaves drugmakers scratching their heads and patients with hope. This milestone moment brings the elusive Alzheimer’s disease to its knees, as Leqembi emerges victorious as the first treatment to earn a prestigious standard approval nod from the FDA.
Hold on to your hats, folks, because this game-changer paves the way for broader insurance coverage of the drug. Trial data speaks volumes, revealing that Leqembi slows down the brain-wasting disease by a whopping 27% for those battling it in its earliest stages. A small step for medicine, but a giant leap for Alzheimer’s patients!
This financial powerhouse, also known as the holder of Peapack-Gladstone Bank, is here to rock your world with top-notch private and commercial banking services, along with wealth management wizardry. They’re not just about numbers; they’re about building meaningful relationships and creating innovative solutions that cater to their customers’ wildest financial dreams.
What sets them apart from the competition? Well, let’s talk about their secret weapons: a seasoned management team, rock-solid customer relationships, and a laser focus on crafting customized financial solutions. With a jaw-dropping 16 banking and 5 wealth management offices in the glorious land of New Jersey, they boast a total asset worth a staggering USD 6.4 billion.
When we size them up against their rivals like Amalgamated Financial Corp. and CrossFirst Bankshares, Peapack-Gladstone Financial Corp emerges as the true superstar. With an impressive earnings per share and a low price-to-earnings ratio that’s practically begging you to invest, they outshine the competition. Oh, and did we mention their profit margin, return-on-equity, revenue, net income, and yield? It’s a royal flush, leaving CrossFirst Bankshares green with envy.
All in all, if you’re an investor seeking a solid anchor that combines strength, success, and a touch of Jersey charm, look no further than Peapack-Gladstone Financial Corp.
Smart investing is all about making informed decisions, and sometimes a little guidance can go a long way! Whether you’re a seasoned investor or just getting started, it never hurts to tap into the wisdom of experts who have navigated the treacherous waters of the market and emerged victorious. Learn from their triumphs, absorb their knowledge, and unlock the secrets to building a rock-solid investment strategy.